Process for preparing rac-bicalutamide and its intermediates

Details Process for preparing rac-bicalutamide and its intermediates Process for preparing rac-bicalutamide and its intermediates

2002-06-13

2004-05-18

Solola, Taofiq (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Sulfur containing

Reexamination Certificate

active

06737550

ABSTRACT:

FIELD OF THE INVENTION
The present invention relates to process for preparing rac-bicalutamide and its intermediates. The prevent invention also relates to micronized rac-bicalutamides and their preparations thereof.
BACKGROUND OF THE INVENTION
Bicalutamide is also known as N-[4-cyano-3-trifluoromethyl-phenyl]-3-[4-fluorophenyl-sulfonyl]-2-hydroxy-2-methyl-propionamide and has the following chemical formula.
Bicalutamide is an acylanilid that has anti-androgen activity. It is known to selectively decrease the testosterone level without influencing the regulation mechanisms of the hypothalamus.
The international patent No. WO 93/19770 describes both R-(−) enantiomer and S-(+) enantiomer for bicalutamide, of which the R-(−) isomer is reported to be more active and possesses lesser side-effects (e.g., headache, gynecomistia and giddiness) when used in therapy treatment.
U.S. Pat. No. 4,636,505 describes processes for preparing acylanilides.
The international Pat. No. WO 01/00608 describes a process for racemic and optically pure N-[4-cyano-3-trifluoromethylphenyl]-3-[4-fluorophenyl-sulfonyl]-2-hydroxy-2-methyl-propionamide. The process involves multiple steps including at least reacting with thionyl choride; hydrolyzing under aqueous basic conditions; sulfonylating with sulfonyl halogenide; and oxidizing with inorganic peroxy salt, or m-chloroperbenzoic acid (MCPBA) or aqueous hydrogen peroxide. However, the synthetic pathways involve the use of substrates (such as sodium hydride) that are dangerously explosive in nature.
There is a constant need to improve the synthesis process for bicalutamide which are economical and environmental safe and feasible.
We have now found a simpler method of preparing bicalutamide and its intermediates without using dangerous oxidizing compounds such as m-chloroperbenzoic acid.
OBJECTS AND SUMMARY OF THE INVENTION
The present invention provides new synthetic pathways for preparing rac-bicalutamide and its intermediates.
According to one object, the present invention is directed to a rac-bicalutamide intermediate having a chemical formula of [X], which represents a stable organo lithium salt of 4-fluorophenyl methyl sulfone.
According to another object, the present invention is directed to a process of preparing [X], comprising the step of reacting 4-fluorophenyl methyl sulfone with butyl lithium to form the organo lithium salt of 4-fluorophenyl methyl sulfone.
According to another object, the present invention provides a novel process for preparing rac-ethyl 1-[2-{4-fluorophenyl sulfone}]-2-hydroxy propionic acid, comprising the step of reacting the organo lithium salt of 4-fluorophenyl methyl sulfone with ethyl pyruvate.
According to another object, the present invention is directed to a rac-bicalutamide intermediate having a chemical formula of [Y], which represents a stable lithium salt of 5-amino-2-cyano-benzotrifluoride.
According to another object, the present invention provides a precess for preparing [Y], comprising the step of reacting 5-amino-2-cyano-benzotrifluoride with butyl lithium to form the lithium salt of 5-amino-cyano-benzotrifluoride.
According to another object, the present invention provides a process for preparing rac-bicalutamide, comprising the step of reacting [Y] with rac-ethyl 1-[2-{4-fluorophenyl sulfone}]-2-hydroxy propionic acid.
According to another object, the present invention provides a process for preparing rac-ethyl-[2-{4-fluorophenyl sulfone}]-2-hydroxy propionic acid, comprising the steps of:
1) mixing 4-fluorophenyl methyl sulfone with butyl lithium to obtain an intermediate having a chemical structure [X];
2) adding ethyl pyruvate; and
3) recovering rac-ethyl-[2-{4-fluorophenyl sulfone}]-2-hydroxy propionic acid.
Preferably, 1,4 diazabicyclo[2.2.2]octane in tetrahydrofuran is used as a stablizied agent in step 1.
According to another object, the present invention provides a process for preparign rac-bicalutamide comprising the steps of:
1) mixing 5-amino-2-cyano-benzotrifluoride and butyl lithium to obtain a lithium salt of 5-amino-2-cyano-benzotrifloride;
2) adding rac-ethyl-[2-{4-fluorophenyl sulfone}]-2-hydroxy propionic acid; and
3) recovering rac-bicalutamide.
Preferably, the step 1) is occurred in the presence of 1,4 diazabicyclo[2.2.2]octane in tetrahydrofuran.
According to one object, the present invention provides a novel process of preparing micronized forms of rac-bicalutamide.
According to another object, the present invention provides a synthesis process of preparing rac-bicalutamide with a particle size in which the mean particle size enhances the rate of dissolution and the reproducibility of dissolution. The present invention provides rac-bicalutamide in which the mean particle size imparts an improved and stable dissolution profile.
According to another object, the present invention provides rac-bicalutamide formulations containing rac-bicalutamide having relatively small particles, and corresponding large surface area.
According to another object, the present invention provides rac-bicalutamide with a particle size which enhances the rate of dissolution and the reproducibility of the rate of dissolution.
According to another object, the present invention provides rac-bicalutamide in which the mean particle size imparts an improved and stable dissolution profile.
According to another object, the present invention provides rac-bicalutamide and formulations containing rac-bicalutamide having a mean particle diameter of less than 200 &mgr;m.
According to another object, the present invention provides a process for preparing micronized rac-bicalutamide.
According to another object, the present invention provides pharmaceutical compositions comprising micronized rac-bicalutamide.


REFERENCES:
patent: 3254094 (1966-05-01), Ross
patent: 4554381 (1985-11-01), Desbois
patent: 4636505 (1987-01-01), Tucker
patent: 5723485 (1998-03-01), Gungor et al.
patent: 6160011 (2000-12-01), Miller et al.
patent: 6184249 (2001-02-01), Sovak et al.
patent: 6291504 (2001-09-01), Nugiel et al.
patent: 6306874 (2001-10-01), Fraley et al.
patent: 6358985 (2002-03-01), Anthony et al.
patent: WO 93/19770 (1993-10-01), None
patent: WO 01/00608 (2001-01-01), None
MacPeek, Donald L. et al., “Synthesis of Glycidic Esters by Epoxidation of &agr;,&bgr;-Unsaturated Esters with Peracetic Acid,” J. Am. Chem., 1959, vol. 81, pp. 680-683.
Emmons, William D. et al., “Peroxytrifluoroacetic Acid. IV. The Epoxidation of Olefins,” J. Am. Chem., 1955, vol. 77, pp. 89-92.
Ho, Winston et al., “Alkylglycidic Acids: Potential New Hypoglycemic Agents,” J. Med. Chem., 1986, vol. 29, pp. 2184-2190.
Lieberman, Herbert A. et al.,Pharmaceutical Dosage Forms: Tablets, vol. 2, 2ndEd., Marcel Dekker, Inc., New York (1990), pp. 107-200.
Database CAPLUS on STN, Chemical Abstracts, CA: 129:244921, Freskos et al., “Preparation of aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds as matrix metalloprotease inhibitors”, no date available.
Database CAPLUS on STN, Chemical Abstracts, CA:128:75188, Takahashi et al., “Preparation and formulation of aryl sulfides, sulfoxides, and sulfones as matrix metalloproteinase inhibitors”, 12/97.
Database CAPLUS on STN, Chemical Abstracts, CA: 136:12767, Slusarek et al., “Color photographic thermally processable film comprising blocked developer compound”, Nov. 2001.
Database CAPLUS on STN, Chemical Abstracts, CA:86:171116, Buettner et al., “Trifluoromethyl-substituted aminobenzonitriles”, 3/77.
Database CAPLUS on STN, Chemical Abstracts, CA:108:150026, Tucker et al., “Resolution of the non-steriodal antiandrogen 4′-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3′-(trifluoromethyl) propionanilide and the determination of the absolute configuration of the active enantiomer”, no data available.
Database CAPLUS on STN, Chemical Abstracts, CA: 2002:414656, James et a

Affiliated with

Also associated with

Rating

Process for preparing rac-bicalutamide and its intermediates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for preparing rac-bicalutamide and its intermediates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing rac-bicalutamide and its intermediates will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3187336